Breaking News

BMS Patents Hydantoin To Reduce Inflammation

November 15, 2005

Patent No. US 6,710,064 B2: Bristol-Myers Squibb Co., Princeton, NJ, earn-ed a patent for the use of hydantoin as an anti-inflammatory agent.
blog comments powered by Disqus